Navigation Links
Cyclodextrin enhances room temperature phosphorescence


Abstract
Cyclodextrin-enhanced room-temperature phosphorescence (CD-RTP) is an analytical technique that offers well-resolved spectra and subpicogram detection limits. When polynuclear aromatic hydrocarbons (PAHs) are included in cyclodextrin molecules in the presence of a heavy-atom moiety such as 1,2-dibromoethane, they exhibit intense, well-defined phosphorescence emissions, often with distinct vibrational structure. Moreover, the cyclodextrin moiety inhibits quenching of PAH phosphorescence by O2 present in the bulk solution.


Introduction
Cyclodextrins (CDs) are made up of glucose monomers coupled to form a rigid, conical structure with an interior hydrophobic cavity. The most common CDs, denoted by α, β, and γ, are composed, respectively, of six, seven, and eight monomers. Initially, each CD contains one or more water molecules, produced during the monomer coupling. Because these included water molecules are easily displaced by hydrophobic species that will fit into the CD interior, cyclodextrins have a unique ability to form stable inclusion complexes with a variety of molecules.

This inclusion capability has led to an important use of cyclodextrins in luminescence spectroscopy. Cyclodextrins have been found to enhance fluorescent and phosphorescent emissions from molecules present in the CD cavity.1,2,3,4,5 Of particular interest is the phenomenon of cyclodextrin-enhanced room-temperature phosphorescence (CD-RTP), which suggests a highly-selective analytical technique based on the molecular geometry of the lumiphor.

Chromophores such as polynuclear aromatic hyrdocarbons (PAHs) exhibit virtually no phosphorescence in conventional fluid media. Scypinski and Cline Love report, however, that intense room-temperature phosphorescence occurs when these well-known carcinogens are present, with an external heavy atom, in the cavity of cyclodextrin.4 Figure 1 depicts the inclusion of a phenanthrene molecule within the cavity of a β-CD. Scypinski and Cline Love also have observed CD-RTP in nitrogen heterocycles and bridged biphenyls.5


A description of the experiments with PAHs will serve to illustrate the technique of CD-RTP, and provide a basis for assessing its advantages.


Experimental Method
Each PAH analyte was dissolved in either methanol or acetone, after which the solvent was gently evaporated. Addition of a 0.10.5-mL aliquot of 1,2-dibromoethane (DBE) was followed by dilution with 0.01-M aqueous CD solution. Upon vigorous shaking, the complex was formed. The cloudy solution obtained was then deoxygenated for fifteen minutes with nitrogen gas prepurified in an Alltech Oxy-Trap.

All spectra were taken on a SPEX FLUOROLOG spectrophotometer with double excitation and emission monochromators. A 450-W xenon CW lamp was used as the excitation source, and a cooled R928 photomultiplier (PMT) tube as the detector. Slits were set to 14.4 nm (excitation) and 3.6 nm (emission). The scan rate was 1 nm s1. All emission spectra were corrected for fluctuations in the intensity of the lamp and PMT responses.


Results and Discussion
The investigation showed the CD-RTP technique to be extremely sensitive, producing intense, well-structured phosphorescence signals at nanomolar concentrations. Detection limits of two typical phosphors, phenanthrene and acenaphthene, were estimated at 5 1013 M and 1 1011 M, respectively. Although the excited triplet state is known to be susceptible to oxygen quenchers, inclusion of the lumiphor inside the CD cavity was observed to offer some protection against quenching by oxygen molecules in the bulk solution. In these experiments, 10% to 40% of the RTP remained after aeration of the samplea signal still strong enough for analytical purposes.

The success of CD-RTP with PAHs depends on the formation of a proposed three-component complex of CD, lumiphor, and external heavy atom. The internal cavity of the CD must be large enough to accommodate both the lumiphor, which must fit at least partially inside, and the heavy atom.


Figure 2 shows the luminescence spectra for phenanthrene included in β-CD, with and without the addition of the heavy-atom DBE. Because the heavy-atom moiety enhances spin-orbit coupling and the rate of inter-system crossings, addition of DBE serves to quench much of the fluorescence while intensifying the phosphorescence.

The physical dimensions of the CD cavities, relative to the geometry of the individual PAH, determined the most effective CD form for each analyte. For example, although the phenanthrene molecule will fit inside the cavity of the α-CD, which has an inner diameter of 0.6 nm, there is apparently not enough room remaining to accommodate the DBE molecule. Both phenanthrene and DBE molecules, however, can be included in the larger β-CD cavity, which has an inner diameter of 0.78 nm. Figure 3 compares the luminescence spectra for the same solution of phenanthrene and DBE in α- and β-CD. Anthracene, which is larger than phenanthrene, showed only weak phosphorescence in βCD, but γ-CD, with an inner diameter of 1.0 nm, induced stronger emissions.


The geometrical limitations imposed by CDRTP may be exploited as a selective means of analysis based on molecular size and shape. For example, it is possible to discriminate between naphthalene, which can be induced to phosphoresce in β-CD, and its bulkier derivative 1-phenylnaphthalene, which shows only fluorescence under the same conditions.

In these experiments, the phosphorescence intensity of the included PAH was found to depend on the concentration of the heavy-atom moiety and on the concentration of CD. Figure 4 illustrates the relationship of the phosphorescence intensity of phenanthrene to the concentration of DBE. As long as the concentration of DBE is low with respect to that of CD, DBE molecules added into the solution are incorporated in the trimolecular inclusion complex, causing a sharp increase in phosphorescence intensity. When the DBE concentration reaches that of the CD, so that complexation is virtually complete, further addition of DBE enhances the phosphorescence only slightly.


Figure 5 demonstrates the dependence of phosphorescence intensity on the concentration of CD. The S-shaped curve traces the phosphorescence intensity of the phenanthrene-DBE solution as β-cyclodextrin is added. The initial steep slope has been attributed to the sharply-increasing probability that a phenanthrene molecule exiting the cavity of a CD-DBE molecule will find another CD-DBE molecule in close proximity.4


Conclusion
Cyclodextrin-enhanced room-temperature phosphorescence shows promise as a sensitive analytical technique. Sample preparation is simple, data-acquisition and processing are easily automated with a FLUOROLOG spectrometer, and the result is an intense, well-structured RTP signal. CD-RTP offers the advantages of increased selectivity based on molecular geometry, and partial immunity to quenching by dissolved O2 molecules.


Acknowledgement
The Fluorescence Group would like to thank Dr. L.J. Cline Love and Stephen Scypinski for their generous cooperation in the preparation of this technical note. We would also like to acknowledge permission from the American Chemical Society to reprint figures originally published in Analytical Chemistry


1 Hoshino, M.; Imamura, M.; Ikehara, K.; Hama, Y. J. Phys. Chem. 1981, 85 , 1820.
2 Turro, N.J.; Bolt, J.D.; Duroda, Y.;Tabushi, I. Photochem. Photobiol. 1982, 35 , 69.
3
Turro, N.J.; Cox., G.S.; Li, X. Photochem. Photobiol. 1983, 37 , 149.
4
Scypinski, S.; Cline Love, L.J. Anal. Chem. 1984, 56 , 322.
5
Scypinski, S.; Cline Love, L.J. Anal. Chem. 1984, 56 , 331.


back to top
'"/>

Source:


Page: All 1 2 3 4 5

Related biology technology :

1. Using Gradient PCR to determine the optimum annealing temperature.
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cyclodextrin enhances room temperature phosphorescence

(Date:12/19/2014)... 2014 Today, TiFiber, Inc. ... production facility and future company headquarters in Fort ... new materials that safely and effectively control dangerous ... of its historic, strong support for manufacturing, but ... leading edge, technology-based companies such as TiFiber. ...
(Date:12/19/2014)... Biddeford, ME (PRWEB) December 18, 2014 ... founding director of the Center for Excellence in the ... of New England, has been selected as a member ... He is the first neuroscientist from Maine to receive ... a nonprofit organization supported entirely by the Dana Foundation. ...
(Date:12/19/2014)... (PRWEB) December 18, 2014 iLab Solutions, ... the appointment of Siri Bryant as the new Director ... Director of Core Implementations. These two new leadership positions ... customer service by ensuring that iLab continues to meet ... the last four years, iLab has been deployed at ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 The ... to the rising ageing population and technological innovations ... and nutraceutical industries are catalysing the growth of ... @ http://www.marketsandmarkets.com/Market-Reports/empty-capsules-market-218018190.html , Scope of Report ... as well as new entrants/smaller firms to gauge ...
Breaking Biology Technology:Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 2Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 3Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 4UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 2UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 3iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4
... (Nasdaq: VRNM ), a pioneer in the ... that it has renewed and extended its joint marketing ... heat transfer, separation and fluid handling technologies, for Purifine® ... agreement to jointly market enzymatic degumming of vegetable oils ...
... SEATTLE, Oct. 26 On Thursday, October ... Central European/5:30 a.m. Pacific, members of Cell ... management team will host a conference call ... financial results.Conference Call NumbersThursday, October 288:30 a.m. ...
... Tengion, Inc. (Nasdaq: TNGN ), a ... Saturday, October 23, 2010 in a podium presentation ... Exchange in Orlando, FL. The presentation highlighted new ... demonstrating promising improvements in kidney function with an ...
Cached Biology Technology:Verenium and Alfa Laval Announce Extension of Purifine® PLC Enzyme Agreement 2Verenium and Alfa Laval Announce Extension of Purifine® PLC Enzyme Agreement 3Verenium and Alfa Laval Announce Extension of Purifine® PLC Enzyme Agreement 4Tengion Presents New Large Animal Data Demonstrating Functional Kidney Regeneration at the American Society for Transplantation Annual Conference 2Tengion Presents New Large Animal Data Demonstrating Functional Kidney Regeneration at the American Society for Transplantation Annual Conference 3Tengion Presents New Large Animal Data Demonstrating Functional Kidney Regeneration at the American Society for Transplantation Annual Conference 4
(Date:12/19/2014)... , Dec. 18, 2014   LaunchKey , ... for the post-password and Internet of Things era, today ... funding. The venture round was led by Metamorphic Ventures ... Rimrock Venture Partners, VegasTechFund, and others.  LaunchKey has raised ... funding to expand its team and bring LaunchKey to ...
(Date:12/17/2014)... , Dec. 16, 2014 Research and Markets ... addition of the "Global Chemical Sensor Market ... http://photos.prnewswire.com/prnh/20130307/600769 One ... increasing demand for medical sensors in biomedical applications. ... for quick and correct diagnosis during surgical procedures. ...
(Date:12/11/2014)... -- That blood pressure plays a role in human health has ... term for high blood pressure – was first described as ... that,s used in measuring blood pressure was invented in 1896. ... hypertension, its triggers and its effects. In fact, recent findings ... best ways to treat it. For example, a ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... , Sept. 18, 2013 Reportlinker.com announces ... available in its catalogue: ... http://www.reportlinker.com/p01623686/Emerging-Opportunities-in-Global-Biometrics-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Security_Systems ... Manifold,This study analyzes the emerging applications in ...
...  GenesisSolutions (An ABS Group Company), a Fully Integrated Global ... Sciences EAM Symposium for Engineering, Maintenance & Reliability professionals ... in Cary, North Carolina . ... provide participants with examples of Asset Management Best Practices ...
... study led by researchers at Children,s National Medical Center ... promise for the treatment of Duchenne muscular dystrophy (DMD). ... , show that the drug, VBP15, decreases inflammation ... effects linked to current treatments with glucocorticoids such as ...
Cached Biology News:Emerging Opportunities in Global Biometrics Market 2Emerging Opportunities in Global Biometrics Market 3Emerging Opportunities in Global Biometrics Market 4Emerging Opportunities in Global Biometrics Market 5Life Sciences EAM Symposium 2Life Sciences EAM Symposium 3New muscular dystrophy treatment shows promise in early study led by Children's National 2
HSD17B3 Immunogen: HSD17B3 (NP_000188, 29 a.a. ~ 120 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Rad51, N-terminal...
Phospho-mu-Opioid Receptor (Ser375) Antibody...
Rabbit polyclonal to WWOX8 ( Abpromise for all tested applications). entrezGeneID: 51741 SwissProtID: Q9NZC7-8...
Biology Products: